Targeting T cell costimulation in autoimmune disease
Authors:
- 1 June 2002
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Therapeutic Targets
- Vol. 6 (3) , 275-289
Abstract
Many factors contribute to the pathogenesis of autoimmune diseases. Targets for treating such debilitating diseases will become more apparent by understanding the nature of immune activation. This review examines the possibility of targeting costimulation and discusses the molecules found on the T cell and the antigen-presenting cell (APC) that participate in T cell activation. Although new molecules continue to be discovered, the functions of B7-1 (CD80), B7-2 (CD86), CD28, cytotoxic T lymphocyte antigen 4 (CTLA-4), inducible costimulator (ICOS), programmed death 1 (PD-1), OX 40 (CD134) and CD40 ligand (CD40L, CD154) are now sufficiently understood that immunologists are targeting them to manipulate T cells to slow the progression of autoimmune diseases or treat tumours through the increase in T cell activation. CD28, ICOS, OX 40 and CD40L are considered the costimulatory molecules that increase T cell activation. However, ICOS and OX 40 appear to act on memory cells while CD28 is predominantly a naive T...Keywords
This publication has 62 references indexed in Scilit:
- Advances in the Treatment of Lupus NephritisAnnual Review of Medicine, 2001
- Activation-Induced Expression of Human Programmed Death-1 Gene in T-LymphocytesExperimental Cell Research, 1997
- B7-1 and B7-2 Have Overlapping, Critical Roles in Immunoglobulin Class Switching and Germinal Center FormationImmunity, 1997
- CD28/B7 Regulation of Th1 and Th2 Subsets in the Development of Autoimmune DiabetesImmunity, 1996
- CD28/B7 SYSTEM OF T CELL COSTIMULATIONAnnual Review of Immunology, 1996
- Treatment of Murine Lupus with CTLA4IgScience, 1994
- The B7 and CD28 receptor familiesImmunology Today, 1994
- Immunosuppression in Vivo by a Soluble Form of the CTLA-4 T Cell Activation MoleculeScience, 1992
- Long-Term Survival of Xenogeneic Pancreatic Islet Grafts Induced by CTLA4lgScience, 1992
- The two-signal model of lymphocyte activation twenty-one years laterImmunology Today, 1992